Effects of Acute Carbohydrate Intake Intra-training in Crosstraining

October 1, 2024 updated by: Lucas Jurado-Fasoli, Universidad de Granada

Effects of Acute Carbohydrate Intake Intra-training in Crosstraining Athletes: a Randomized, Placebo-controlled Crossover Study

This study aims to investigate the effect of acute carbohydrate intake during a crosstraining session on exercise-induced muscle damage and the recovery of crosstraining athletes.

Study Overview

Status

Completed

Conditions

Detailed Description

Carbohydrate intake during exercise could decrease the subjective perceived exertion and promote recovery during high-intensity and intermittent exercises such as crosstraining. Nevertheless, despite extensive research on carbohydrate ingestion during exercise across different sports disciplines, its effects have not been investigated in crosstraining sessions.

23 male trained crosstraining athletes will ingest carbohydrates (60g of maltodextrin + fructose, 2:1 ratio) or placebo during a one-and-a-half-hour crosstraining session. The session will consist of a warm-up, a weightlifting part, a strength part, a WOD, and an AMRAP. The rating of perceived exertion (RPE) will be assessed using the validated Borg scale at the beginning of the session, after each part of the training, and at the end of the session. DOMS will be assessed using a visual analog scale at 24 and 48 hours after the crosstraining session.

Study Type

Interventional

Enrollment (Actual)

25

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Granada, Spain
        • University of Granada

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Age: 18-35 years.
  • Body mass index: 18.5-30 kg/m2.
  • Ability to understand the instructions, objectives, and study protocol.
  • Minimum of 3 years of experience in crosstraining, with at least 6 hours of weekly training over the past 3 months.
  • Resident on the island of Tenerife.

Exclusion Criteria:

  • History of a significant adverse cardiovascular event, renal insufficiency, cirrhosis, eating disorder, weight control surgical intervention, or type 2 diabetes mellitus.
  • Any chronic condition in which the intake of nutritional supplements is not advisable.
  • Any condition that, in the investigator's judgment, would impair the ability to participate in the study or represent a personal risk to the participant.
  • Use of medications that may affect the study results.
  • Unstable body weight for 3 months prior to the start of the study (> 4 kg loss or gain in - weight).
  • Active tobacco abuse or illicit drug use, or history of treatment for alcohol abuse.
  • On a special diet or prescribed for other reasons (e.g., celiac disease).

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Quadruple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Carbohydrates
60g of maltodextrin + fructose, 2:1 ratio
60g of maltodextrin + fructose, 2:1 ratio
Placebo Comparator: Placebo
Preparation of colorants, sweeteners, aromas and acidulants
Placebo

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Exercise-induced muscle damage and recovery measured through the countermovement jump
Time Frame: 1 hour 30 minutes
Countermovement jump height
1 hour 30 minutes
Exercise-induced muscle damage and recovery through the DOMS scale
Time Frame: 1 hour 30 minutes
Delayed-onset muscle soreness (DOMS) scale (0-10 arbitrary units)
1 hour 30 minutes

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Feeling sensations
Time Frame: 1 hour 30 minutes
Feeling scale
1 hour 30 minutes
Capillar lactate levels
Time Frame: 1 hour 30 minutes
Capillar lactate levels
1 hour 30 minutes
Capilar glucose levels
Time Frame: 1 hour 30 minutes
Capilar glucose levels
1 hour 30 minutes
Subjective fatigue throughe the RPE scale
Time Frame: 1 hour 30 minutes
Rate of perceived exertion scale
1 hour 30 minutes
Performance: Weight used in the crosstraining session
Time Frame: 1 hour 30 minutes
Weight used in the crosstraining session
1 hour 30 minutes
Performance: Repetitions performed in the crosstraining session
Time Frame: 1 hour 30 minutes
Repetitions performed in the crosstraining session
1 hour 30 minutes
Performance: Rounds performed in the crosstraining session
Time Frame: 1 hour 30 minutes
Rounds performed in the crosstraining session
1 hour 30 minutes

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 1, 2024

Primary Completion (Actual)

June 1, 2024

Study Completion (Actual)

September 1, 2024

Study Registration Dates

First Submitted

May 21, 2024

First Submitted That Met QC Criteria

May 27, 2024

First Posted (Actual)

June 3, 2024

Study Record Updates

Last Update Posted (Actual)

October 3, 2024

Last Update Submitted That Met QC Criteria

October 1, 2024

Last Verified

October 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • CROSSCARB

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Recovery

Clinical Trials on Placebo

Subscribe